Results

eNauka >  Rezultati >  Can pharmacogenetic variants in TPMT, MTHFR and SLCO1B1 genes be used as potential markers of outcome prediction in systemic sclerosis patients?
Naziv Can pharmacogenetic variants in TPMT, MTHFR and SLCO1B1 genes be used as potential markers of outcome prediction in systemic sclerosis patients?
Autori: Jelovac, Marina  ; Kotur, Nikola  ; Ristivojević, Bojan  ; Pavlović, Đorđe  ; Spasovski, Vesna  ; Damjanov, Nemanja; Pavlović, Sonja  ; Zukić, Branka  
Godina: 2023
Publikacija: CoMBoS2 – the Second Congress of Molecular Biologists of Serbia, Abstract Book – Trends in Molecular Biology, Special issue 06-08 October 2023, Belgrade, Serbia
Izdavač: Institute of Molecular Genetics and Genetic Engineering (IMGGE), University of Belgrade
Tip rezultata: Konferencijski rad
ISBN: 978-86-7078-173-3 Pretraži identifikator
Kolacija: str. 64-64
URI: https://imagine.imgge.bg.ac.rs/handle/123456789/2119
https://enauka.gov.rs/handle/123456789/834734
Projekat: Ministarstvo prosvete, nauke i tehnološkog razvoja Republike Srbije, Ugovor br. 200042 (Univerzitet u Beogradu, Institut za molekularnu genetiku i genetičko inženjerstvo)
M-kategorija: 
Mp kategorija će biti prikazana naknadno.

Find the DOI


Google ScholarTM

Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.